Abstract: Methods and apparatus for delivering content may include receiving a direction of travel for a wireless device and selecting a route of travel for the wireless device that proceeds in the given direction to maximize an amount of contact with one or more access terminals capable of providing data connectivity. In addition, the methods and apparatus may include providing content to the wireless device via the data connectivity provided by the one or more access terminals along the selected route of travel.

Abstract: Embodiment methods and systems enable personal navigation devices to warn drivers during turn-by-turn navigation directions when they are approaching a difficult turn. Personal navigation devices may report to a server when a turn is missed during turn-by-turn directions, including identifying the turn and situation information. The server may aggregate missed turn reports from many personal navigation devices to generate a difficult turn database. Personal navigation devices may access the difficult turn database when generating turn-by-turn directions to identify turns requiring enhanced directions. The difficult turn database may be stored on personal navigation devices, and/or may be maintained on the server. Personal navigation devices may be configured to recognize when turns are intentionally missed, and only report missed turns when they determined that the turn was missed unintentionally.

Abstract: The present invention relates to a continuous process for producing a haloalkenone ether of the Formula (I) wherein R1 is C1-C6 haloalkyl, R2 is a C1-C6 alkyl or phenyl, the process comprising:—(i) reacting, in a first continuous stirred tank reactor comprising a solvent, a halide of Formula (II) wherein R1 is as previously defined and R3 is halogen, with a vinyl ether of Formula (III) wherein R2 is as previously defined, to form an intermediate compound of Formula (IV), wherein the concentration of the vinyl ether of Formula (III) in the reaction mass is 15% or less w/w; and (ii) transferring the reaction mass from the first continuous stirred tank reactor into a subsequent continuous stirred tank reactor, wherein the conditions within the subsequent reactor permit the elimination of hydrogen halide (HR3) from the intermediate compound of Formula (IV) to provide the haloalkenone ether of Formula (I).

Abstract: Apparatus and methods for recommending a navigation destination based upon recent updates are provided. The apparatus and methods include, in one or more aspects, receiving a request from a user communication device for a desired item, and associating a user location of the user communication device with a destination location of a provider of the desired item. Further, the one or more aspects include identifying a destination communication device at the destination location, and querying the destination communication device for a human-originating response to obtain a current accessibility status of the desired item. Additionally, the one or more aspects include reporting the destination location of the provider and the current accessibility status to the user communication device.

Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.

Abstract: Described herein is a system and method for migrating data from a source storage site to a destination storage site. The data may be comprised within storage objects (e.g., flexible volumes). A base storage object may comprise a parent storage object and a storage object clone may comprise a storage object that is derived from the base storage object. As such, a hierarchical relationship exists between the base storage object and the storage object clone. The storage object clone may comprise a writable point-in-time image of the parent storage object. If a migration of the base storage object and the storage object clone is performed, then the hierarchical relationship between the base storage object and the storage object clone is retained after the storage objects are migrated from the source storage site to the destination storage site. As such, the system and method for migrating data may enable storage space and network bandwidth savings.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: The present invention relates to a continuous process for producing a haloalkenone ether of the Formula (I) wherein R1 is C1-C6 haloalkyl, R2 is a C1-C6 alkyl or phenyl, the process comprising:—(i) reacting, in a first continuous stirred tank reactor comprising a solvent, a halide of Formula (II) wherein R1 is as previously defined and R3 is halogen, with a vinyl ether of Formula (III) wherein R2 is as previously defined, to form an intermediate compound of Formula (IV), wherein the concentration of the vinyl ether of Formula (III) in the reaction mass is 15% or less w/w; and (ii) transferring the reaction mass from the first continuous stirred tank reactor into a subsequent continuous stirred tank reactor, wherein the conditions within the subsequent reactor permit the elimination of hydrogen halide (HR3) from the intermediate compound of Formula (IV) to provide the haloalkenone ether of Formula (I).

Abstract: Methods and systems for rapidly rolling back and retrying a data migration between a first and a second storage system. In one embodiment, upon receiving a request at a provisioning manager to perform a rollback of a first data migration, the first storage system merges, to a baseline dataset, a first incremental dataset received by the second storage system after the first data migration. In another embodiment, upon receiving a request at a provisioning manager to perform a retry of the data migration, the second storage system merges, to the data received by the second storage system during and immediately after the first data migration, a second incremental dataset received to the first storage system after performance of the rollback. Throughout the migration rollback and retry, the data of the baseline dataset, first incremental dataset, and second incremental data set is made available to the client.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: An adaptive user interface device capable of implementing multiple modes of input and configuration may adapt to current user inputs, and may include configuration changes. In an aspect, an adaptive user interface device may be configured for a finger sensing in a touchpad mode, and configured for stylus sensing in a digital tablet mode. In another aspect, surface features of the adaptive user interface device may change shape, such as by raising buttons in response to entering a keyboard or keypad mode. Various mechanisms may be used for raising buttons, and may enable presenting buttons in a variety of shapes and locations on the interface. The configuration of the adaptive user interface device may depend upon the user actions and user identity. Configuration modes may be organized according to many levels enabling a single user interface to support a large number of input options functionality within a limited surface area.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: In a particular embodiment, a method includes applying a first feature detector to a portion of an image to detect a first set of features. The first set of features is used to locate a region of interest, and a boundary corresponding to the region of interest is determined. The method also includes displaying the boundary at a display. In response to receiving user input to accept the displayed boundary, a second feature detector is applied to an area of the image encapsulated by the boundary.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: The technology relates to monoclonal antibodies useful in the identification of cancer cells. In one embodiment, mAbs with specificity for tumor antigens are provided. In one embodiment, methods for treating cancer using mAbs are provided. In another embodiment, methods for detecting cancerous cells are provided. In another embodiment, kits for detecting cancerous cells are provided.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.

Abstract: An application management server may automatically disable applications or widgets that are incompatible with a user's computing device, and automatically re-enable such applications or widgets when the user's computing device is compatible. Auto-disabled applications may be tracked in memory of a server by setting an auto-disabled status indication associated with the disabled application or widget. If an auto-disabled application or widget is upgraded or the user swaps computing devices, thereby resolving the incompatibility, the server may auto-enable such applications and widgets that were previously auto-disabled so that they may be downloaded to or used from the user's computing device. The server may recognize when a software upgrade resolves an incompatibility and prompt a computing device to initiate a synchronization process to receive the auto-enabled application or widget to the computing device or to the user's application server-based locker or profile.